Raffles Medical eyes China healthcare growth but stays prudent on expansions
PRIVATE healthcare provider Raffles Medical Group : BSL 0% has its eyes fixed on continuing to drive growth, even as it grapples with a slowdown in medical tourism amid the Covid-19 pandemic.
When Singapore shut its borders in early 2020, foreigners seeking medical help here had to be turned away. Private healthcare players who relied heavily on medical tourism turned to other avenues to get their care to overseas patients, including online consultations and delivering medication straight to patients’ homes.
While some companies would have baulked at the sudden shift in operations, Raffles Medical took the changes in stride.
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
IBM to add 800 AI-related jobs in Ireland
Uber unveils US shuttle service, expands Costco tie-up to woo price-conscious users
Grab’s Q1 loss narrows to US$115 million; raises adjusted Ebitda target
Gold prices edge higher as US dollar, yields soften
Singapore shares advance after global indices hit all-time highs; STI up 0.5% at Thursday’s open
China’s Nio launches Onvo brand to challenge Tesla’s best-selling model